Background: Genetic correlation and pleiotropic effects among psychiatric disorders have been reported. This study aimed to identify specific common genetic variants shared between five adult psychiatric disorders: schizophrenia, bipolar, major depressive disorder, attention deficit-hyperactivity disorder, and autism spectrum disorder.
INTRODUCTION
The genome-wide association study (GWAS) has emerged as a compelling tool for investigating the genetic architecture and the etiology of complex human diseases  Correspondence: Fengyu Zhang, zhangfy@gcatresearch.org, or Kun Xia, xiakun@sklmg.edu.cn over the past decade [1] . Many common genetic variants have been associated with complex human disorders through GWAS since the early studies in type 2 diabetes and inflammatory bowel disease [2, 3] . As the application of the GWAS approach has progressed, more and more gen-ome-wide genotyped data have been accumulated, which has made it possible to conduct genome-wide meta-analyses of multiple cohorts of GWAS samples [4] . The number of genome-wide association studies that involve a large number of patients and healthy controls are increasing every year. As of 2017, about 40% of recent studies are with a sample size of more than 50,000 individuals [5] , and some even with more than 200,000 [6, 7] . With samples of such size, investigators expect to identify variants with lower frequency and smaller effect size, by overcoming genetic heterogeneity [8] to attain adequate power to detect a genetic association. More importantly, with the development of genotype imputation and large whole-genome sequencing datasets available, it is feasible to assess the whole genome common variants for association with common complex human disorders without whole genome sequencing of all sample individuals.
The lessons from GWAS include that association of genetic variants with common human disorders is complex and involves a matrix of polygenic and pleiotropic effects. It has become clear that common complex human disorders are affected by multiple variants in a polygenic way [9] ; whereas an individual variant may be associated with multiple diseases or traits (i.e., pleiotropic). Preliminary evidence of pleiotropic effects has been found in immune-related disorders, various types of cancers, or neuropsychiatric disorders [10] . For example, genetic varints at 3p21, 10q24, and SNPs within two L-type voltage-gated calcium channel subunits, CACNA1C and CACNB2 have been found to be shared by multiple psychiatric disorders [11] . Coincidentally, genome-wide SNPs association analysis has revealed that psychiatric disorders might share a moderate to high degree of genetic correlation [12] . Identification of the pleiotropic effects of specific genetic variants on common complex human disorders is a potentially important step in building the knowledge network and a measurement matrix for disease risk for developing a new taxonomy of human diseases, which will play a fundamental role in achieving the goals of precision medicine [13, 14] .
METHODS

Dataset and analysis.
Individual SNP data used in this study were obtained from the published data releases by the Psychiatric Genomic Consortium that contained the largest genome-wide association studies of schizophrenia (SCZ), bipolar disorder (BD) [15] , and major depressive disorder (MDD) [7] , attention deficit hyperactivity disorder (ADHD) [16] , and autism spectrum disorder (ASD) [17] . Detailed information on the sample individuals, original data process and analysis of individual sample cohort has been described previous in the individual studies. Of note, the ADHD sample mainly include a population-based cohort of ADHD cases and controls from Denmark collected by the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), and 11 cohorts aggregated by the Psychiatric Genomics Consortium (PGC); the majority of the ASD sample was also from iPSYCH ASD and five family-based samples of European ancestry, which contributed cases and pseudocontrols.
The analysis was performed by calculating the combined p values of individual SNPs across the genome in multiple disorders. The Stouffer's Z-score method (1949), an extension of classical Fisher's combined method (1925) that has been employed in previous GWAS [18] , was used to have a two-sided test. The hypothesis would be "multiple psychiatric disorders shared some common genetic variants," and under a null hypothesis, a statistic can be calculated by a combined Z-score, which can be converted into p-value based on the inverse of the standard normal cumulative distribution. The Z-score is defined as Z=
; where k is the number of individual disorders, and the is the inverse of the standard normal cumulative distribution based on the p value for an individual SNP in the th disorder.
The analysis was limited to SNPs showing a consistent direction of association at nominal significance (P< 0.05) across disorders, to keep internal consistency and reduce heterogeneity, i.e., ruling out SNPs, which is highly significant in one disorder, but not the other or shows opposite allelic directionality across disorders. The combined analysis was performed first for schizophrenia, bipolar and major depressive disorder, i.e., the three adult psychiatric disorders that have been demonstrated a moderate to high genetic correction, then for ADHD and ASD, the two childhood neurodevelopmental disorders, and finally for five disorders combined. A genome-wide significance threshold (P<5x10 -08 ) was employed.
SNP functional annotation and eQTL analysis. Individual SNPs were mapped to a locus based on the dbSNP and the HapMap data [19] , and then the unmapped SNPs by the database were manually verified with the UCSC genome browser (GRCh37/hg19). Functional annotation of associated loci was performed based on the DAVID Bioinformatics Resource 6.8 using Gene Ontology (GO) term [20] . The eQTL analysis was performed on the GTEx dataset developped by the Genotype-Tissue Expression (GTEx) Project; the gene expressions in human tissues were based on the Human Protein Atlas (HPA) RNA-seq (https://www.proteinatlas.org/). Common variants associated with schizophrenia, bipolar and major depressive disorder
RESULTS
We identified 6,293 SNPs shared by three adult-onset disorders at genome-wide significance (P<5x10 -08 ). These included 2,583 SNPs in the extended major histocompatability complex (xMHC), which spans a 7.5-Mb region defined by the SLC17A2 gene at the telomeric end to the DAXX gene at the centromeric end of chromosome 6 (Chr6:25,875,084-33,797,216, hg19) and mapped to 421 loci (excluding tRNA genes)according to the gene map of xMHC [21, 22] ; and 3,710 SNPs were located in the nonxMHC ( Figure 1A ). We noted that these SNPs were in strong linkage disequilibrium (LD) and clustered by genomic region. Of the total non-xMHC SNPs, 3,654 SNPs (98.5%) were mapped to 68 genomic regions, defined by which flanking SNPs of any two regions were at least 1-Mb apart. Based on the SNP functional prediction [19] , 263 SNPs ( 8%) were at TFBS, and 109 SNPs (3.3%) were conserved in vertebrates (Table S2 ). Among the 68 regions at non-xMHC loci, 51 regions did not have an SNP associated with a particular disorder at genome-wide significance; whereas other 17 regions cotained at least one SNPs in each region associated with an individual disorder at genome-wide significance. In the 51 regions that might be novel or specifically shared by the three adult-onset disorders ( Functional annotation of the genes in the non-xMHC indicated a few top biological processes, including urate metabolic process, protein phosphorylation, and sodium-dependent phosphate transport. These loci are located at a-xon, postsynaptic membrane and postsynaptic density, mitochondrion, cell junction, voltage-gated calcium channel complex, and mitochondrial inner membrane; and they have molecular functions of sodium phosphate symporter activity, sodium-dependent phosphate transmembrane transporter activity, protein binding, p53 binding, ephrin receptor binding, and voltage-gated calcium channel activity involved in AV node cell action potential. However, few of these clustering survived the correction for multiple testing (Table S3) .
ADHD and ASD shared loci
Our combined analysis of 8,047,420 SNPs in 38,266 cases with ADHD or ASD and 63,160 controls identified 1,108 SNPs shared by the two childhood psychiatric disorders at genome-wide significance ( Figure 1B ). These SNPs were located at 47 genomic regions, of which flanking SNPs of any two adjacent regions were at least 1-Mb apart. (Table S5 ). However, we did not find any SNPs shared by ADHD and ASD in the xMHC where a large number of SNPs in strong LD were found shared by the three adult-onset disorders. *, Regions where SNPs were associated with either ADHD or ASD; BP1 and BP2 are position for flanking SNP1 and SNP2.
Of the total 1,108 SNPs shared by ADHD and ASD, 1,095 SNPs were mapped to 63 genes including intergenic regions (Table S6 ) and 912 SNPs (82.3%) were annotated based on the dbSNP [19] . We noted that five SNPs were non-synonymous (Table S7) (Table 3 ). All these 63 genes together annotated a few biological processes, cellular component, and molecular functions, but none of these functional annotations and clustering were significant after multiple testing correction (Table S10 ).
Genetic variants shared by all five disorders
Through a combined analysis of 6,391,075 SNPs available common to all five studies, we identified 713 SNPs at 47 genes in 24 genomic regions (defined as above) shared by all five disorders at genome-wide significance (Figure 2A) . We note that no SNPs were associayed with schizophrenia ( Figure 2B ), Bipolar ( Figure 2D ) or ASD ( Figure 2E) ; but SNPs NUDT12||RAB9P on 5q21.2-21.3 and 10q24-25 have been associated with ADHD ( Figure  2C ) and MDD ( Figure 2E ), respectively. SNPs at NUDT12 ||RAB9P appear in strong LD in multiple original studies (Figure 2 C, E, F) and SNPs at 10q24-25 were mapped to multiple genes including BLOC1S2, CHUK, CWF19L1, ERIN1, PKD2L1, and SORCS3. The locus 10q24 has been identified in a previous genome-wide analysis of shared effect by five psychiatric disorders. In the 22 novel genomic regions that did not contain an SNP associated with the particular disorder at genomewide significance, six SNPs, including rs7945989 at PKP4, rs9375138 at C6orf167,rs12376855 at PCSK5, rs67525-828 at CIZ1,rs9804545 at CWF19L2,rs3099047 at CAST-PER2, were shared by the five disorders (Table 4) . Except for CACNB2 that has been found shared by five disorders, we found additional 40 gene loci in the remaining regions, including A2BP1, RIMS1, DFNA5, CNTN4, MPP6, PLC1, RFTN2, SLC30A9, PAQR3, ERLIN1, SORCS3, ZNF584, and ZNF132. The detailed estimates of flanking SNPs at the total 24 regions are in the supplementary (Table S11) .
Of the 24 genomic regions that harbored SNPs shared by the five disorders, all had been reported with CNVs associated with ASD (only 15q15.3 known for schizophrenia) and more than half were identified with expression quantitative trait loci (eQTLs) ( Table S12 ). About two-thirds of the CNVs disrupted genes; for example, the CNV at 3p-26.3 were associated with CNTN6 and CNTN4, 6q13 with RIMS1, 7p15.3 with MPP6 and DFNA5, 16p13.3 with A2-BP1, and 19q13.43 with ZNF584. In addition, we identified SNPs in more than 13 genomic regions as eQTLs in human tissues through cis-association analysis of the flanking SNPs or alternatives with mRNA expression of the mapped genes. (Table 4) . Additionally, we found that SNP rs3099047 at CATSPER2 had cis-association with about 19 genes in the same region.
Further, we noted that 387 of 713 SNPs shared by five disorders were discovered neither in the analysis of three adult disorders or ADHDASD. However, they were involved in the majority of the genomic regions where the shared 713 SNPs are located (Table S13) . We also noted that 146 SNPs were shared by both the three adult-onset disorders and ADHDASD ( Figure S1 ), and they were located at a 400-kb intergenic region NUDT12||RAB9P1 on 5-q21.2 and SORCS3 on 10q24-25. The SORCS3 encodes a type-I receptor transmembrane protein, a member of the vacuolar protein sorting 10 (VSP10) receptor family, and had a biased expression in the human brain tissues of the Human Protein Atlas dataset.
DISCUSSIONS
We conducted a genome-wide association combined analysis of five major psychiatric disorders with an identification of 336 loci shared by three adult psychiatric disorders, 63 loci by ADHD and ASD, and 47 independent loci in 24 genomic regions associated with the combined all five disorders. The more loci shared among three adult disorders were consistent with a recent study that the overlapping gene expression pattern in human brains that SCZ, BD, and MDD have a moderate to high level of transcriptome correlation, but a low correlation with ASD, indicated [23] . Our study reveal a different genetic architecture, in particular the xMHC region, but some shared common variants between the childhood and adultonset psychitric disorders.
In the present study, we found a substantial heterogeneity of genetic variants shared by three adult-onset psychiatric disorders and two childhood disorders. The analysis of a large number of SNPs across the genome indicated that the xMHC SNPs shared by three adulthood disorders had stronger associations with SCZ and MDD than bipolar disorder, but the two childhood disorders did not share them. In addition, three adulthood psychiatric disor-ders shared a number of non-xMHC loci including DR-D2, GRIN2A, GABRA1, GABRG2, KCNB1, and CACNAI1, in particular CACNA1C, TSNARE1, KLC1, MYTIL that have been found differentially methylated in the human prefrontal cortex between schizophrenia and controls [24] , suggesting that these variants may be associated with the risk of the adulthood psychiatric disorders through an epigenetic mechanism. However, none of these genes were found overlapped with that mapped by the SNPs shared by the two childhood disorders. Further, among SNPs at 63 loci shared by ADHD and ASD, only two loci at NUDT12||RAB9P1 and SORCS3 were common to the three adult psychiatric disorders. Given that, 80% of SNPs shared by two childhood disorders are located at genomic regions with CNVs known for ASD; it may support that CNVs contribute to the genetic causes of two childhood disorders significantly, at least for ASD [25] . However, this study was not aimed to focus on CNVs or rare mutations, which have been implicated for the biology of autism spectrum disorder [26] .
Despite the noted heterogeneity for the loci between adult-onset and childhood disorders, new novel or specific loci were identified for five disorders, and they indicate that neurodevelopmental genes may play a role in the development of a spectrum of major psychiatric disorders. First, all of the loci shared by the five disorders were located at genomic regions with CNVs reported for ASD. Previous studies have found that both microdeletions and microduplications greater than 100-kilobases disrupt genes in the neurodevelopmental pathway in schizophrenia [27] . Several genes identified are worthy of mention here. A2BP1 has been identified as the top candidate gene in one of two network modules revealed through transcriptome analysis of differentially expressed genes between autism and controls in post-mortem human brains [28] . Disruption of CNTN4 has been shown to result in developmental delay and contributing to the 3p deletion syndrome [29] . CATSPER2 encodes a protein in the family of cation channel proteins that localize to the flagellum of spermatozoa; defects at this locus cause male infertility, and further a single SNP rs3099047 at CATSPER2 was shown as a significant cis-association with nearly 20 genes in the GTEx dataset. Moreover, we noted that 102 SNPs in a 5-Mb region on 10q24.31-25.1 were mapped to multiple genes and they were eQTLs for BLOC1S2 and SO-RCS3 in multiple human tissues; and 2-3 Mb de novo deletions within this region have been detected in individuals with mental retardation and multiple congenital anomalies [30] . All these findings support that the genetic variants shared by the five disorders play a role in neurodevelopment and may through this general mechanism contribute to risk for all psychiatric disorders.
Further, the loci shared by five disorders may have implications for common neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). Of the loci shared by five psychiatric disorders, genetic variants at SOCRS3 and CACNB2 have been assoc- iated with Alzheimer's disease, and both genes had a biased expression in normal brain tissues of the Human Protein Atlas RNA-Seq data. Knockdown of SORCS3 in cell culture leads to an increase in amyloid precursor protein (APP) processing, and APP may be as a mediator of the synapse pathology in the AD [31] . Common genetic variants at CACNB2 have been associated with AD or through a within-locus SNP by SNP interaction [32] . In addition, we identified five SNPs at microtubule-associated protein tau (MAPT) that were shared by ADHD and ASD.
Common genetic variants at MAPT have been associated with the risk of the late-onset AD, and also of PD in an early large family-based study [33] , and shared by AD and PD [34] . Mutations in MAPT have also been detected in the early-onset AD and MAPT-related disorders, a group of neurological disorders including frontotemporal dementia with parkinsonism-17 (FTDP-17), progressive supranuclear palsy (PSP), cortico-basal degeneratetion (CB-D), and mild late-onset parkinsonism, dementia with epilepsy.
Finally, it is worth highlighting that our study identified multiple shared genes CACNA1C, TSNARE1, KLC1, and MYTIL for three adult disorders that have been found differentially methylated in the human prefrontal cortex between schizophrenia and controls in a recent study [24] . Findings of genetic loci would provide a clue about what kind of environment would have caused the high methylation at individual genes associated with psychiatric disorders or a biological basis for conducting geneenvironment interaction analyses. While the collection of environmental data is essential for a complete study of the etiology for common human disorders in the future, the effect that environmental factors exert on humans has to be through the human genome. It would be a great challenge to measure environmental factors across lifespan compared to measure the variants across the whole genome. What is more, most of the lifestyle and behavioral factors are not exogenous, and genetic variants might influence them. In addition to the further neurobiological study, our study provides a manageable list of anchors from which to investigate epigenetic mechanism or gene-gene interaction on the development of neuropsychiatric disorders.
In summary, we identify a sizeable number of genetic variants shared by three psychiatric disorders diagnosed during adulthood, by two childhood disorders, and by all five disorders. These variants indicate genetic heterogeneity but also point to the genetic etiology of neurodevelopment in five major psychiatric disorders or other neurological disorders. Our study provides new insights into genetic etiology and may have important implications for precision neuropsychiatry or medicine.
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